More evidence of BCG against COVID-19

3,424 Views | 10 Replies | Last: 5 yr ago by Keegan99
Snap E Tom
How long do you want to ignore this user?
Yes, blah blah blah - there's a ton of confounding issues that are at play, but it's a close statistical look at mortality of countries that immunize against BCG versus those that don't.

https://www.medrxiv.org/content/10.1101/2020.04.01.20049478v1

TL;DR - BCG vaccinated countries are having lower mortality rates.
Caleb12
How long do you want to ignore this user?
AG
Thought this thread was about billy Clyde at first...
astros4545
How long do you want to ignore this user?
AG
He should have never left us for Kentucky

But I wish him well at his new job
Tailgate88
How long do you want to ignore this user?
AG
ham98
How long do you want to ignore this user?
The coach is doin' work!!!
Snap E Tom
How long do you want to ignore this user?
Glad this thread is going this direction instead of a bunch of nitpicking debbie downers who don't know what the word "evidence" means chiming in.
Cepe
How long do you want to ignore this user?
McInnis
How long do you want to ignore this user?
AG
The use of TLAs in theses threads without reference has become intolerable.
Doctor Rosenrosen
How long do you want to ignore this user?
AG
Safe at Home said:

The use of TLAs in theses threads without reference has become intolerable.
Irony intended?
Sq 17
How long do you want to ignore this user?
I would be curious if there is an underlying demographic difference
5StarShield
How long do you want to ignore this user?
AG
For those that were in the dark like me...

Quote:

BCG, or bacille Calmette-Guerin, is a vaccine for tuberculosis (TB) disease.
Keegan99
How long do you want to ignore this user?
AG
Interesting real world experiment in East and West Germany.





From the nature article...

"We read with great interest the recent thorough study from Miller et al. [1], who reported a beneficial impact of early Bacillus CalmetteGurin (BCG) vaccination, and linked morbidity and mortality due to SARS-CoV-2 with BCG vaccination policy. They found that countries without policies of universal BCG vaccination (like Italy, the Netherlands, or the United States) have been more severely affected compared with countries with universal and long-standing BCG policies. Since senior citizens are particularly sensitive to COVID-19, newborn vaccination programs implemented in the 1940s and 1950s should be the most beneficial. Thus, we were impressed by the linear correlation between the year of the establishment of universal BCG vaccination and the mortality rate presented by Miller et al. [1]. In our view, this is a convincing argument for the hypothesis that the earlier the vaccination policy was established, the larger the segment of the elderly population being protected.

We would like to make the scientific community aware of a unique historical circumstance in Germany, where divergent BCG vaccination policies existed in the politically divided country (19491989) before German reunification in 1990. In East Germany, BCG vaccination programs were established by the communist government in 1951, and soon became compulsory in 1953, leading to near-universal (99.8%) BCG vaccination of newborns by day 3. By contrast, voluntary BCG vaccination (recommended since 1955) was far less common in West Germany, due to low incidence of the disease after the Second World War. In early years, only 720% of all newborns became BCG-vaccinated in Western Germany, with almost complete cessation of vaccination between 1975 and 1977 (Fig. 1a). Thus, we believe that the comparison of morbidity and mortality of SARS-CoV-2 would be particular informative in the light of the rather uniform genetic, social, and cultural background. Here, we record those data in formerly East and West German federal states (excluding Berlin, Fig. 1b). Our observations strongly support the analysis from Miller et al., and point toward BCG vaccination having a protective effect. "
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.